Skip to main content
. 2020 Jun 1;201(11):1389–1397. doi: 10.1164/rccm.201909-1807OC

Table 2.

Any Day Ancillary Use for Overall Maximum PALICC ARDS Severity in the 72-Hour Study Period

Adjunctive Therapy, Any Day (n = 624) NIV (n = 66) Mild (n = 124) Moderate (n = 178) Severe (n = 256) All (n = 624) P Value
cNMB 0 (0.0) 16 (12.9) 51 (28.7) 129 (50.4) 196 (31.4) <0.001
Corticosteroids for PARDS 6 (9.1) 5 (4.0) 20 (11.2) 33 (12.9) 64 (10.3) 0.059
iNO 1 (1.5) 2 (1.6) 11 (6.2) 67 (26.2) 81 (13.0) <0.001
Prone positioning 1 (1.5) 1 (0.8) 14 (7.9) 47 (18.4) 63 (10.1) <0.001
HFOV 0 (0.0) 1 (0.8) 1 (0.6) 56 (21.9) 58 (9.3) <0.001
ECMO 0 (0.0) 1 (0.8) 2 (1.1) 16 (6.3) 19 (3.0) 0.002

Definition of abbreviations: ARDS = acute respiratory distress syndrome; cNMB = continuous neuromuscular blockade; ECMO = extracorporeal membrane oxygenation; HFOV = high-frequency oscillatory ventilation; iNO = inhaled nitric oxide; NIV = noninvasive ventilation; PALICC = Pediatric Acute Lung Injury Consensus Conference; PARDS = pediatric acute respiratory distress syndrome.

Results are presented as n (%). Subjects were grouped into worse severity in the first 72 hours of PARDS diagnosis.